International Pemphigus and Pemphigoid Foundation скачать в хорошем качестве

International Pemphigus and Pemphigoid Foundation

Pemphigus is a group of rare autoimmune blistering diseases of the skin and/or mucous membranes. It is chronic and progressive condition that usually begins in the oral mucosa. Typically patients will have had multiple oral ulcers (broken blisters) that persist for weeks to months. Before the advent of corticosteroids, pemphigus had a high fatality rate, with approximately 70+% of patients dying within a year. With treatment, lesions can heal normally without scarring and the hyperpigmentation associated with pemphigus often resolves after several months. However, remission is fairly common. Pemphigoid is a group of sub-epidermal, blistering autoimmune diseases that primarily affect the skin, especially the lower abdomen, groin, and flexor surfaces of the extremities. Treatment usually includes corticosteroids, such as prednisone, and other drugs that suppress the immune system. Bullous pemphigoid can be life-threatening, especially for older people who are already in poor health. The International Pemphigus & Pemphgoid Foundation (IPPF) provide patients and doctors worldwide with information about pemphigus and pemphigoid, and to provide patients and their caregivers much needed comfort and support so they can continue to live active, productive lives. In this exclusive interview with Marc Yale from IPPF, he talks about these little known conditions and the role IPPF is playing in improving patients lives -- including access to the upcoming Patient Conference this April in Chicago.